Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Bevacizumab and ICIs + hSRT in Symptomatic Melanoma Brain Metastases	Melanoma Brain Metastases	Recruiting	Phase 1 / Phase 2	2025-05-13		NCT06163820

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Melanoma and Skin Cancer Trials Limited	10

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alfred Health	Melbourne	Australia	32

Clinical trials